Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version ...
Medical Device Network on MSN
FDA clears Android version of Tandem Mobi mobile application
The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi ...
Tandem Diabetes Care's t:slim X2 Insulin Pump Automated Insulin Delivery System is now the first to incorporate the Abbott FreeStyle Libre 2 Plus Sensor for users in the United States. The FreeStyle ...
The technology went through the FDA’s new interoperability pathway, which encourages device-makers to build products that can be used across systems or platforms. Both Tandem Diabetes’ software and ...
Tandem Diabetes Care has received the Food and Drug Administration’s green light for the Tandem Mobi insulin pump for people with diabetes aged 6 years old and older. The Tandem Mobi is fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback